Skip to main content
. 2012 Mar 2;2(3):e59. doi: 10.1038/bcj.2012.3

Table 2. Allogeneic stem cell transplantation for myelofibrosis.

Author N Median age (years) 1-year TRM, % 5-year overall survival, % 5-year progression free-survival, %
Ballen et al.15 289 47 27 (sibling), 43 (unrelated) 37 (sibling), 30 (unrelated) 33 (sibling), 27 (unrelated)
Patriarca et al.16 100 49 35 31 28
Robin et al.17 147 53 29 (4 years) 39 (4 years) 32 (4 years)
Kerbauy et al.22 104 47 27 61 (7 years)
Deeg et al.21 56 43 35 58

Abbreviation: TRM, transplant-related mortality.